Splitomicin
-
- Application
- Inhibition (Inh)
- Purpose
- SIRT1 inhibitor
- Characteristics
- Initially shown to inhibit Sir2p (the yeast Sirt1 homolog) and create a conditional phenocopy of a sir2 deletion mutant in S. cerevisiae. Cells grown in the presence of the drug have silencing defects at telomeres, silent mating-type loci and the ribosomal DNA. Inhibits all class III HDACs (sirtuins) and alleviates gene silencing in Fragile X mental retardation syndrome. Reverses ischemic preconditioning-induced cardioprotection in a mouse model.
- Purity
- >98 %
- Chemical Name
- 1,2-Dihydro-3H-naphtho[2,1-b]pyran-3-one
- Formula
- C13H10O2
- Solubility
- Soluble in DMSO (up to 25 mg/ml) or in Ethanol (up to 25 mg/ml).
-
-
- Restrictions
- For Research Use only
-
- Format
- Powder
- Storage
- RT
-
- Background
- Splitomycin,Epigenetics,Protein deacetylase,Ischemia,Heart disease,Posttranslational modification,Chromatin
- Molecular Weight
- 198.22
- CAS-No
- 5690-03-9
-